These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21934723)

  • 1. New anticoagulation drugs for atrial fibrillation.
    Potpara TS; Lip GY
    Clin Pharmacol Ther; 2011 Oct; 90(4):502-6. PubMed ID: 21934723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
    Garwood CL; Hwang JM; Moser LR
    Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New antithrombotics for atrial fibrillation.
    Bereznicki LR; Peterson GM
    Cardiovasc Ther; 2010 Oct; 28(5):278-86. PubMed ID: 20645985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in oral anticoagulation for atrial fibrillation.
    Singh M; Adigopula S; Patel P; Kiran K; Khosla S
    Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):395-407. PubMed ID: 20965952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now?
    Dzeshka MS; Lip GY
    Trends Cardiovasc Med; 2015 May; 25(4):315-36. PubMed ID: 25440108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pharmacotherapy for stroke prevention in atrial fibrillation: update 2010.
    Armaganijan L; Eikelboom J; Healey JS; Morillo CA
    Adv Ther; 2009 Dec; 26(12):1058-71. PubMed ID: 20127214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances].
    Gorzelak P; Zyzak S; Krewko Ł; Mozdzan M; Broncel M
    Pol Merkur Lekarski; 2014 May; 36(215):302-6. PubMed ID: 24964505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New avenues for anticoagulation in atrial fibrillation.
    Mantha S; Cabral K; Ansell J
    Clin Pharmacol Ther; 2013 Jan; 93(1):68-77. PubMed ID: 23212107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial.
    De Caterina R; John Camm A
    Europace; 2016 Jan; 18(1):6-11. PubMed ID: 26450845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.
    Moreno-Arribas J; Bertomeu-González V; Anguita-Sanchez M; Cequier Á; Muñiz J; Castillo J; Sanchis J; Roldán I; Marín F; Bertomeu-Martínez V;
    J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):150-6. PubMed ID: 26229096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of vitamin K antagonist and new oral anticoagulants use in atrial fibrillation: a Danish drug utilization study.
    Pottegård A; Poulsen BK; Larsen MD; Hallas J
    J Thromb Haemost; 2014 Sep; 12(9):1413-8. PubMed ID: 25039280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
    Martí-Fàbregas J; Mateo J
    Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New oral anticoagulants in atrial fibrillation.
    Turpie AG
    Eur Heart J; 2008 Jan; 29(2):155-65. PubMed ID: 18096568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients.
    Di Minno MN; Russolillo A; Di Minno A; Camera M; Parolari A; Tremoli E
    Expert Opin Emerg Drugs; 2013 Mar; 18(1):9-23. PubMed ID: 23448155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meeting the unmet needs in anticoagulant therapy.
    Weitz JI
    Eur J Haematol Suppl; 2010 Jul; (72):1-28. PubMed ID: 20553560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal trends in the prescription of vitamin K antagonists in patients with atrial fibrillation.
    Friberg J; Gislason GH; Gadsbøll N; Rasmussen JN; Rasmussen S; Abildstrøm SZ; Køber L; Madsen M; Torp-Pedersen C
    J Intern Med; 2006 Feb; 259(2):173-8. PubMed ID: 16420546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments.
    Schirmer SH; Baumhäkel M; Neuberger HR; Hohnloser SH; van Gelder IC; Lip GY; Böhm M
    J Am Coll Cardiol; 2010 Dec; 56(25):2067-76. PubMed ID: 21144965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' attitude and knowledge about oral anticoagulation therapy: results of a self-assessment survey in patients with atrial fibrillation conducted by the European Heart Rhythm Association.
    Amara W; Larsen TB; Sciaraffia E; Hernández Madrid A; Chen J; Estner H; Todd D; Bongiorni MG; Potpara TS; Dagres N; Sagnol P; Blomstrom-Lundqvist C
    Europace; 2016 Jan; 18(1):151-5. PubMed ID: 26462697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New oral anticoagulants should not be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation.
    Ansell J
    Circulation; 2012 Jan; 125(1):165-70; discussion 170. PubMed ID: 22215891
    [No Abstract]   [Full Text] [Related]  

  • 20. [What is the current use of vitamin K antagonists in the elderly?].
    Vidal JS; Hanon O
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):17-22. PubMed ID: 24463060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.